期刊论文详细信息
BMC Musculoskeletal Disorders
Lumbar spine fusion outcomes using a cellular bone allograft with lineage-committed bone-forming cells in 96 patients
Bradley Wetzell1  Kimberly Dorsch1  Marshall Gillette1  Andrea Rowland1  Hassan Semaan1  Julie B. McLean1  Mark A. Moore1  Christopher A. Balboa1  Hossein Elgafy1  Thomas A. Mierzwa1 
[1] Department of Orthopaedic Surgery, University of Toledo Medical Center, 3065 Arlington Avenue, 43614, Toledo, OH, USA;
关键词: Cellular bone allograft;    CBA;    Lumbar fusion;    Instrumented posterior lumbar fusion;    IPLF;    TLIF;    Transforaminal interbody fusion;    ViviGen;   
DOI  :  10.1186/s12891-021-04584-z
来源: Springer
PDF
【 摘 要 】

BackgroundInstrumented posterior lumbar fusion (IPLF) with and without transforaminal interbody fusion (TLIF) is a common treatment for low back pain when conservative interventions have failed. Certain patient comorbidities and lifestyle risk factors, such as obesity and smoking, are known to negatively affect these procedures. An advanced cellular bone allograft (CBA) with viable osteogenic cells (V-CBA) has demonstrated high fusion rates, but the rates for patients with severe and/or multiple comorbidities remain understudied. The purpose of this study was to assess fusion outcomes in patients undergoing IPLF/TLIF using V-CBA with baseline comorbidities and lifestyle risk factors known to negatively affect bone fusion.MethodsThis was a retrospective study of de-identified data from consecutive patients at an academic medical center who underwent IPLF procedures with or without TLIF, and with V-CBA. Baseline patient and procedure characteristics were assessed. Radiological outcomes included fusion rates per the Lenke scale. Patient-reported clinical outcomes were evaluated via the Oswestry Disability Index (ODI) and Visual Analog Scale (VAS) for back and leg pain. Operating room (OR) times and intraoperative blood loss rates were also assessed.ResultsData from 96 patients were assessed with a total of 222 levels treated overall (mean: 2.3 levels) and a median follow-up time of 16 months (range: 6 to 45 months). Successful fusion (Lenke A or B) was reported for 88 of 96 patients (91.7%) overall, including in all IPLF-only patients. Of 22 patients with diabetes in the IPLF+TLIF group, fusion was reported in 20 patients (90.9%). In IPLF+TLIF patients currently using tobacco (n = 19), fusion was reported in 16 patients (84.3%), while in those with a history of tobacco use (n = 53), fusion was observed in 48 patients (90.6%). Successful fusion was reported in all 6 patients overall with previous pseudarthrosis at the same level. Mean postoperative ODI and VAS scores were significantly reduced versus preoperative ratings.ConclusionThe results of this study suggest that V-CBA consistently yields successful fusion and significant decreases in patient-reported ODI and VAS, despite patient comorbidities and lifestyle risk factors that are known to negatively affect such bony healing.

【 授权许可】

CC BY   

【 预 览 】
附件列表
Files Size Format View
RO202109175229577ZK.pdf 1091KB PDF download
  文献评价指标  
  下载次数:5次 浏览次数:1次